Pharmacists Reviewed the Medical Orders for Intravenous Medication and Their Intervention Analysis  

作　　者：ZHOUHuachen 

机构地区：[1]JiyangPeople'sHospitalofJi’nan,Ji’nan251400,China

出　　处：《外文科技期刊数据库(文摘版)医药卫生》2022年第7期166-170,共5页

摘　　要：Objective: to explore the effect of pharmacists after reviewing intravenous medication orders and conducting interventions. Methods: with 200 intravenous medication orders from May 2020, 100 clinicians and 200 intravenous treatment patients from May 2019 to May 2020 to differentiate before and after the pharmacist review of intravenous drug orders. The 100 intravenous medication orders, 50 clinicians, and 100 intravenous treatment patients were assigned as the control group. The post-intervention group was set as the observation group. The sample size was consistent with the control group. The unreasonable rate of medical orders in the list of medical orders, the incidence of adverse reactions after intravenous infusion, intravenous medication knowledge, and qualified rate of intravenous drug orders, complaints and patient satisfaction of the two groups were evenly input into the statistical form for calculation and analysis. Results: 100 intravenous medication orders from the observation group and the control group were selected, and the incidence of unreasonable medication orders in the observation group was lower (P 0.05). The incidence of adverse effects in the observation group was lower than that in the control group (P 0.05). Doctors in the observation group had a higher level of intravenous medication knowledge (P 0.05). After the intervention was reviewed by the pharmacists medical advice, the qualification rate of the doctors in the observation group was significantly at a higher level (P 0.05). The observation group had a higher rate of intravenous medication complaints and a higher level of satisfaction (P 0.05). Conclusion: the review of intravenous drug orders and launching corresponding intervention measures according to the unreasonable medical orders can reduce the incidence of adverse reactions during intravenous treatment, improve the rationality and standardization of patients issued by clinicians medical orders, reduce the complaint rate of patients, and significantly improve the safety guara

关 键 词：intravenous therapy intravenous medical advice review pharmacist intervention qualified rate ADV 

分 类 号：R952[医药卫生—药学] R969.3